2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dostert, P; Nagatsu, T; Naoi, M; Niwa, T; Takeda, N; Tatematsu, A; Yoshida, M; Yoshizumi, H | 2 |
2 other study(ies) available for 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Biogenic Amines; Brain Chemistry; Female; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Male; Parkinson Disease; Tetrahydroisoquinolines | 1991 |
Presence of tetrahydroisoquinoline-related compounds, possible MPTP-like neurotoxins, in parkinsonian brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Biotransformation; Culture Techniques; Dopamine; Frontal Lobe; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Neurotoxins; Parkinson Disease; Structure-Activity Relationship; Tetrahydroisoquinolines | 1993 |